Guillaume Mousseau

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment

Cari F. Kessing, Christopher C. Nixon, Chuan Li et al. · Cell Reports · 2017 · 248 citations · Full text

Hiv-1 Treatment, Neurovirology, Vivo Suppression +11

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency

Guillaume Mousseau, Cari F. Kessing, Rémi Fromentin et al. · mBio · 2015 · 223 citations · Full text

An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription

Guillaume Mousseau, Mark A. Clementz, Wendy Bakeman et al. · Cell Host & Microbe · 2012 · 194 citations · Full text

Neurovirology, Medicine, Human Retrovirus +3

1-Protected 5-amido 1,2,3-triazoles via ruthenium-catalyzed [3+2] cycloaddition of azides and ynamides

Sophie Oppilliart, Guillaume Mousseau, Li Zhang et al. · Tetrahedron · 2007 · 82 citations

Engineering, 1-Protected 5-Amido 1,2,3-Triazoles, Organic Chemistry +4

Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat

Sonia Mediouni, Krishna Chinthalapudi, Mary Krishna Ekka et al. · mBio · 2019 · 81 citations · Full text